Lymphoproliferative disorder during temozolomide therapy; a representative case of a formidable complication and management challenges

BACKGROUND: Lymphoproliferative disorder represents a heterogeneous clinicopathological spectrum characterized by uncontrolled proliferation of lymphocytes. Immunodeficiency is a major trigger of its development. While induction of immunodeficiency is a well-known adverse effect of temozolomide ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Sato, Daisuke, Takami, Hirokazu, Takayanagi, Shunsaku, Taoka, Kazuki, Tanaka, Mariko, Matsuura, Reiko, Tanaka, Shota, Saito, Nobuhito
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10251676/
https://www.ncbi.nlm.nih.gov/pubmed/37296412
http://dx.doi.org/10.1186/s12883-023-03274-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10251676/
https://www.ncbi.nlm.nih.gov/pubmed/37296412
http://dx.doi.org/10.1186/s12883-023-03274-8

Ejemplares similares